This map shows the geographic impact of Lever Af's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lever Af with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lever Af more than expected).
This network shows the impact of papers produced by Lever Af. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lever Af. The network helps show where Lever Af may publish in the future.
Co-authorship network of co-authors of Lever Af
This figure shows the co-authorship network connecting the top 25 collaborators of Lever Af.
A scholar is included among the top collaborators of Lever Af based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Lever Af. Lever Af is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Lyall, Fiona, et al.. (1988). Vascular hypertrophy and hypertension: a role for growth factors?. PubMed. 571. 189–96.4 indexed citations
2.
Af, Lever. (1987). Slow pressor mechanisms and smooth muscle mitogens in hypertension.. Journal of Clinical Hypertension. 3(3). 323–327.5 indexed citations
3.
McMillan, I, et al.. (1987). Demonstration of an extra-renal mechanism in post-deoxycorticosterone hypertension.. PubMed. 19(1 Pt 2). 1113–4.5 indexed citations
4.
Ji, Robertson, et al.. (1986). The pathophysiology of renovascular hypertension.. PubMed. 4(4). S95–103.29 indexed citations
5.
Lasaridis, Anastasios N., Brown Jj, Daryl L. Davies, et al.. (1984). Arterial blood pressure and plasma and body electrolytes in idiopathic hyperaldosteronism: a comparison with primary hyperaldosteronism (Conn's syndrome) and essential hypertension.. PubMed. 2(4). 329–36.5 indexed citations
6.
Af, Lever, et al.. (1984). Renal secretion of inactive renin and extraction of angiotensin II in renal artery stenosis in man: factors determining renal vein renin ratio.. PubMed. 2(3). S255–8.1 indexed citations
7.
Davies, Daryl L., C Beretta-Piccoli, Brown Jj, et al.. (1983). Body sodium and blood pressure: abnormal and different correlations in Conn's syndrome, renal artery stenosis and essential hypertension.. PubMed. 20. 483–8.
8.
Davies, Daryl L., et al.. (1979). Aldosterone and its stimuli in normal and hypertensive man: are essential hypertension and primary hyperaldosteronism without tumour the same condition?. PubMed. 81(2). 79P–91P.29 indexed citations
9.
Kremer, D., K. Boddy, Brown Jj, et al.. (1978). Amiloride in the treatment of primary hyperaldosteronism and essential hypertension.. PubMed. 4. 55–63.7 indexed citations
10.
Jj, Brown, et al.. (1976). Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol.. Institutional Research Information System (Università degli Studi di Brescia). 3(4 Suppl 3). 799–803.36 indexed citations
11.
Jj, Brown, et al.. (1976). The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.. PubMed. 12. 230–41.6 indexed citations
12.
Jj, Brown, et al.. (1975). The clinical value of renin and angiotensin estimations.. PubMed. S181–201.9 indexed citations
13.
Gavras, Haralambos, Noëlynn Oliver, Charles F. Begg, et al.. (1975). Abnormalities of coagulation and the development of malignant phase hypertension.. PubMed. S252–61.12 indexed citations
14.
Gavras, Haralambos, Charles F. Begg, Brown Jj, et al.. (1973). Microangiopathic haemolytic anaemia in malignant phase hypertension.. PubMed. 35(8). 863–863.1 indexed citations
15.
Jj, Brown, et al.. (1969). Hypothesis: renin and angiotensin as a mechanism of diuretic-induced antidiuresis in diabetes insipidus.. PubMed. 197–217.1 indexed citations
16.
Krück, F., P. Vecsei, Brown Jj, et al.. (1968). [Psychosomatic syndrome with gastrointestinal and-or renal potassium and sodium depletion, hyperreninnemia and secondary aldosteronism].. PubMed. 98(48). 1883–92.4 indexed citations
17.
Jj, Brown, et al.. (1967). De veranderde positie van de verpleegkundige in de Wet BIG. Tijdschrift voor Gezondheidsrecht. 32(1). 203–217.6 indexed citations
18.
Jj, Brown, Lever Af, & Robertson Ji. (1967). Renin and angiotensin in health and disease.. PubMed. 97(49). 1635–9 contd.11 indexed citations
19.
Jj, Brown, Daryl L. Davies, Lever Af, Parker Ra, & Robertson Ji. (1966). The assay of renin in single glomeruli and the appearance of the juxtaglomerular apparatus in the rabbit following renal artery constriction.. PubMed. 30(2). 223–35.30 indexed citations
20.
Af, Lever, et al.. (1961). Blood flow and blood pressure after noradrenaline infusions.. PubMed. 21. 69–74.15 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.